Hyperfine (NASDAQ:HYPR) Stock Picked Up by Analysts at Lucid Cap Mkts

Lucid Cap Mkts initiated coverage on shares of Hyperfine (NASDAQ:HYPR) in a research note issued on Tuesday, Zacks reports. The brokerage set a “strong-buy” rating on the stock.

Several other equities analysts have also issued reports on HYPR. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Hyperfine in a report on Thursday, October 15th. Loop Capital set a $2.00 price objective on Hyperfine in a report on Tuesday. BTIG Research reissued a “buy” rating and issued a $2.00 price objective on shares of Hyperfine in a research report on Tuesday, September 22nd. Finally, B. Riley Financial restated a “buy” rating and set a $1.60 target price (down from $2.00) on shares of Hyperfine in a research note on Monday, August 10th. One analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $2.02.

Hyperfine Stock Up 4.7%

Shares of Hyperfine stock opened at $0.78 on Tuesday. The firm’s 50 day moving average price is $0.82 and its 200-day moving average price is $1.13. The company has a quick ratio of 5.45, a current ratio of 6.15 and a debt-to-equity ratio of 0.36. Hyperfine has a 52-week low of $0.70 and a 52-week high of $1.94. The company has a market cap of $83.21 million, a P/E ratio of -2.06 and a beta of 1.45.

Hyperfine (NASDAQ:HYPR) last posted its quarterly earnings data on Thursday, August 6th. The company reported ($0.09) EPS for the quarter, hitting the consensus estimate of ($0.09). Hyperfine had a negative net margin of 210.75% and a negative return on equity of 97.88%. The firm had revenue of $3.90 million during the quarter, compared to analyst estimates of $4.13 million. On average, sell-side analysts predict that Hyperfine will post -0.34 EPS for the current fiscal year.

Institutional Trading of Hyperfine

Several large investors have recently bought and sold shares of HYPR. PFS Partners LLC raised its holdings in shares of Hyperfine by 150.0% in the third quarter. PFS Partners LLC now owns 50,000 shares of the company’s stock worth $40,000 after buying an additional 30,000 shares during the last quarter. Walleye Capital LLC lifted its stake in shares of Hyperfine by 3.4% during the first quarter. Walleye Capital LLC now owns 223,988 shares of the company’s stock worth $242,000 after buying an additional 7,330 shares during the period. Bank of New York Mellon Corp acquired a new stake in shares of Hyperfine during the second quarter worth $419,000. Finally, Renaissance Technologies LLC grew its holdings in shares of Hyperfine by 100.2% during the first quarter. Renaissance Technologies LLC now owns 730,233 shares of the company’s stock valued at $789,000 after buying an additional 365,490 shares during the last quarter. Hedge funds and other institutional investors own 15.03% of the company’s stock.

Hyperfine Company Profile

Hyperfine, Inc (NASDAQ: HYPR) is a medical technology company focused on making magnetic resonance imaging more accessible and convenient. The company develops portable, low-field MRI technology designed to bring brain imaging directly to patients in locations such as intensive care units, emergency departments, operating rooms and other point-of-care settings.

Hyperfine’s primary product is the Swoop Portable MR Imaging System, a compact MRI platform that can be moved to a patient’s bedside.